Patent · US Expired

Benzimidazole compounds and drugs containing the same

US6593323B1 · kind B1 · utility

0Cited by
1References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 3, 2002
Grant dateJul 15, 2003
Priority date
Expiry dateJun 3, 2022

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A benzimidazole compound or a salt thereof which has an inhibitory action of forming of macrophages and is useful as an active ingredient of a medicament for preventive and/or therapeutic treatment of arteriosclerosis, which is represented by the formula (I): wherein, R1 represents a functional group on the benzene ring selected from the group consisting of hydrogen atom, a halogen atom, a lower alkyl group and a lower alkoxy group; R2 represents hydrogen atom, an alkyl group or an acyl group; R3 represents a functional group on the ring containing the nitrogen atom and Z; Z represents a divalent group which forms a 5- or 6-membered ring; L represents a C4-C8 alkylene group or an ethyleneoxy linking group represented by (CH2CH2O)nCH2CH2 wherein n represents 1 or 2; and X represents O or S.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.